Most clinical research on vitamin K2 supplements has used daily doses of 90 to 180 micrograms of the MK-7 form, with some trials going up to 360 micrograms. There is no official recommended daily intake specifically for K2, since current dietary guidelines lump it together with vitamin K1. That gap between research and regulation makes choosing a dose more complicated than it should be, and the right amount for you depends on which form of K2 you’re taking, what health outcome you care about, and whether you’re on certain medications.
Why There Is No Official K2 Dose
When government health agencies set a recommended intake for “vitamin K,” they’re really talking about vitamin K1, the form found in leafy greens. K2, which comes from fermented foods and animal products, gets bundled under the same umbrella even though it behaves differently in the body. K2 is absorbed differently, stays in the bloodstream longer, and activates certain proteins that K1 does not effectively reach. A growing number of researchers have argued that K2 needs its own recommended intake separate from K1, precisely because the two forms have distinct roles.1MDPI (Nutrients). Vitamin K2 Needs an RDI Separate from Vitamin K1 Until regulators catch up, the dosing guidance we have comes almost entirely from clinical trials rather than any official standard.
MK-4 Versus MK-7 and Why the Subtype Changes the Dose
Vitamin K2 is not a single molecule. It’s a family of compounds called menaquinones, and the two you’ll encounter in supplements are MK-4 and MK-7. They differ in ways that matter a lot for dosing. MK-4 has a short half-life in the blood. In a comparison study, MK-4 showed a small area under the curve and disappeared from the bloodstream quickly compared to longer-chain menaquinones, which lingered much longer.2PubMed Central. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women Because MK-4 clears so fast, the doses used in Japanese bone health trials are enormous by comparison, typically 45 milligrams per day, which is about 250 times larger than a standard MK-7 dose.
MK-7, on the other hand, builds up in the blood over days of consistent use and reaches a steady state. Its longer half-life means you need far less of it. Nearly all the Western clinical trials that have driven supplement formulations have used MK-7 in the microgram range. When people talk about taking “100 to 200 micrograms of K2,” they almost always mean MK-7. If your supplement label says MK-4, the dosing math is entirely different, and comparing the two microgram-for-microgram makes no sense.
Doses Studied for Bone Health
The most commonly cited dose in bone research is 180 micrograms of MK-7 daily. A three-year trial gave healthy postmenopausal women either that dose or a placebo. During the first year bone loss was similar in both groups, but by the end of three years, MK-7 had a measurable positive effect on bone strength markers, including a significant difference in age-adjusted impact strength, even after controlling for age and body weight.3Metabolism – Clinical and Experimental. Vitamin K and bone health: A review on local effects with emphasis on the pharmacological mechanisms of action A related analysis of the same population found that MK-7 preserved the microarchitecture of trabecular bone at the tibia. In the placebo group, trabeculae thinned and spaced out in a pattern consistent with normal aging. In the MK-7 group, that deterioration essentially didn’t happen over 12 months.4PubMed. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women
A lower dose has also shown promise. A randomized trial in middle-aged and elderly Chinese participants found that 90 micrograms of MK-7 per day significantly reduced bone loss at the femoral neck in postmenopausal women compared to placebo. Interestingly, adding calcium and vitamin D3 on top of the K2 didn’t produce additional benefit in that study.5PubMed. Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study The effect was specific to postmenopausal women; men in the same trial didn’t see the same benefit.
The evidence isn’t unanimous, though. A separate three-year trial giving 375 micrograms of MK-7 daily to postmenopausal women with low bone density found no difference in bone mineral density between the supplement and placebo groups at any site.6PubMed. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial That result is a useful reminder that the bone evidence for K2 is mixed and that the benefits, where they appear, tend to show up in bone quality and microstructure rather than straightforward density scores. Bone density measured by standard scans doesn’t capture everything going on inside the bone.
Doses Studied for Cardiovascular Markers
The cardiovascular case for K2 centers on a protein called matrix Gla protein, or MGP. When you don’t have enough vitamin K, MGP stays in an inactive form and can’t do its job of keeping calcium out of your artery walls. The inactive form of this protein is used as a marker of vitamin K deficiency in the cardiovascular system. In a 12-week supplementation trial, 180 micrograms of MK-7 per day reduced this inactive marker by about 31 percent, while 360 micrograms reduced it by about 46 percent. The placebo group showed no change.7PubMed. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein Both doses also improved osteocalcin markers, another vitamin K-dependent protein, in a dose-dependent pattern.
These are biomarker changes, not direct evidence that taking K2 prevents heart attacks. The logic is reasonable: activate the protein that keeps calcium in bones and out of arteries, and you should get less arterial calcification over time. But long-term cardiovascular outcome trials of K2 supplementation are still limited, particularly in healthy populations. The biomarker data supports 180 micrograms as a meaningful dose for activating these protective proteins, with higher doses activating them further.
The Warfarin Problem
If you take warfarin or another vitamin K antagonist anticoagulant, K2 supplementation is a serious concern. Warfarin works by blocking vitamin K’s role in blood clotting, so adding K2 directly opposes the drug’s mechanism. What’s surprising is how little it takes. Research has found that MK-7 supplementation influenced anticoagulation sensitivity at doses as low as 10 micrograms per day. At just 45 micrograms daily, group mean INR (the standard measure of blood-thinning) dropped by roughly 40 percent.8The Dr Kumar Discovery. How Much Vitamin K2 Per Day Should You Take? Even 10 micrograms per day produced a clinically relevant INR drop in at least 40 percent of subjects. That’s a fraction of the dose found in most K2 supplements, which typically start at 100 micrograms.
Higher pharmacological doses of K2 (in the milligram range, as sometimes used perioperatively) also showed dose-dependent effects on anticoagulation, causing delayed INR normalization after warfarin was restarted.9PubMed Central. Effect of vitamin K2 on the anticoagulant activity of warfarin during the perioperative period of catheter ablation The bottom line: if you’re on warfarin or a similar drug, do not add K2 supplements without your doctor adjusting your anticoagulation monitoring. The interaction is real, it’s dose-dependent, and it starts at doses well below what most supplements contain.
Taking K2 with Vitamin D
You’ll frequently see K2 bundled with vitamin D3 in combination supplements, and there’s a biochemical rationale for it. Vitamin D helps your body absorb calcium, but it doesn’t direct where that calcium ends up. K2-dependent proteins are involved in routing calcium into bones and teeth rather than letting it deposit in soft tissues like artery walls. This “calcium paradox,” where vitamin D supplementation could theoretically increase both bone calcium and arterial calcium, is a proposed reason to pair the two.10PubMed Central. Beyond Bone Health: Exploring the “Heart-Brain-Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2)
A trial in patients with type 2 diabetes found that the combination of vitamins D and K together appeared to improve osteocalcin carboxylation and markers related to bone and glucose balance, suggesting individual and joint effects.11PubMed Central. Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus The synergy argument is plausible, but the evidence base for D3+K2 as a combo outperforming either alone is still developing. Many of the combination supplements on the market pair vitamin D doses in the 1,000 to 5,000 IU range with 100 to 200 micrograms of MK-7, which tracks with the individually studied ranges for each nutrient.
How to Absorb It
K2 is fat-soluble, meaning it needs dietary fat to be absorbed efficiently. Taking a K2 capsule on an empty stomach with just water is a good way to waste most of it. The practical fix is simple: take it with a meal that contains some fat. Even a small amount of fat in the meal is enough to trigger the bile secretion that helps pull fat-soluble vitamins into your bloodstream. Many supplement manufacturers dissolve MK-7 in an oil base inside softgel capsules for exactly this reason. Research into dissolution of K2 in oils like sunflower oil has confirmed that the lipophilic nature of the vitamin makes oil an effective carrier for improving gastrointestinal absorption.12International Education and Research Journal. EXPLORING THE DISSOLUTION OF VITAMIN K2 IN SUNFLOWER OIL: INSIGHTS AND APPLICATIONS
Your gut bacteria also produce some menaquinones on their own, and there’s direct evidence that bacterially synthesized K2 is absorbed from the lower small intestine and contributes to your vitamin K status.13PubMed. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K Gut microbes can also remodel dietary vitamin K into bacterial menaquinones.14PubMed Central. Dietary vitamin K is remodeled by gut microbiota and influences community composition How much this endogenous production actually contributes to your daily needs is uncertain, but it means your effective K2 status isn’t determined by supplements alone. People who have had extensive antibiotic use, gut surgeries, or conditions that alter their microbiome may get less from this internal source.
Food Sources Worth Knowing About
The single richest food source of MK-7 is natto, a Japanese fermented soybean dish with a famously strong smell and slimy texture. A study feeding volunteers different concentrations of natto found that standard natto contains roughly 775 micrograms of MK-7 per 100 grams, and fortified versions can contain over 1,700 micrograms per 100 grams. Eating natto significantly raised both circulating MK-7 levels and markers of activated osteocalcin.15PubMed. Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals A single serving of natto delivers several times the amount of MK-7 found in a typical supplement capsule.
Other fermented foods contain K2 in smaller amounts. Certain hard and aged cheeses (particularly Gouda and Edam), egg yolks, butter from grass-fed cows, and organ meats like liver all provide some menaquinones, mostly shorter-chain forms like MK-4. If natto isn’t something you can eat regularly (and for most people outside Japan, it’s an acquired taste at best), getting meaningful K2 from diet alone requires consistent intake of multiple K2-containing foods. Supplements exist precisely because most Western diets are quite low in this nutrient.
Trans Versus Cis Isomers in Supplements
Not all MK-7 supplements are created equal at a molecular level. MK-7 can exist in different geometric forms, and only the all-trans form is biologically active. Synthetic production methods can introduce cis isomers that your body can’t use effectively. The isomer composition of the final product depends on the production method, purification process, and storage conditions.16Applied Microbiology and Biotechnology. Cis and trans isomers of the vitamin menaquinone-7: which one is biologically significant? MK-7 produced through traditional bacterial fermentation (the same process used to make natto) tends to yield a higher proportion of the all-trans form. Some cheaper synthetic preparations may contain a mix of cis and trans isomers, meaning the label dose overstates the biologically useful amount.
If you’re choosing a supplement, this is one of those areas where quality varies meaningfully between products. Look for brands that specify all-trans MK-7 or that use fermentation-derived MK-7. Third-party testing certifications can also help, since they verify that the active isomer content matches the label.
Special Populations and Adjusted Dosing
People with chronic kidney disease are a population where K2 research has been especially active. Kidney disease progressively depletes vitamin K stores, and arterial calcification is a major cause of cardiovascular events in these patients. The inactive form of MGP (the same biomarker improved by K2 supplementation in healthy adults) has been repeatedly linked to calcification and worse cardiovascular outcomes in kidney disease populations.17PubMed Central. Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet? Clinical trials in this group are ongoing, and the doses being tested tend to be in the same 90 to 360 microgram range used in healthy populations, though the rationale for supplementation may be stronger given how depleted these patients tend to be.
Children represent another population where K2 has drawn attention. A review of the literature found that MK-7 has a documented history of safe use and no reported adverse effects in children, including those with various malabsorption conditions like cystic fibrosis and inflammatory bowel disease.18PubMed Central. The Impact of Vitamin K2 (Menaquionones) in Children’s Health and Diseases: A Review of the Literature Pediatric doses in the research tend to be lower than adult doses, often in the 45 to 90 microgram range, though no standardized pediatric recommendation exists.
K2 and Dental Health
The same proteins that K2 activates in bones are present in teeth. Osteocalcin, when properly carboxylated by vitamin K, helps bind calcium to the mineral matrix that makes up both bone and tooth structure. Research into periodontitis has found that normal K2 levels enable carboxylation of vitamin K-dependent proteins like periostin and matrix Gla protein, which are active in the tissues supporting your teeth.19PubMed Central. A Case Control Study Evaluating the Relationship between Vitamin K2 Serum Level and Periodontitis The dental connection is a logical extension of the bone biology. Whether K2 supplementation can meaningfully improve dental outcomes in people who are already getting enough K1 is not yet settled, but the mechanistic basis is there, and it’s one of the areas where future trials will likely sharpen the picture.
Putting the Numbers Together
If you’re a generally healthy adult looking at MK-7 supplements, the range of 100 to 200 micrograms per day aligns with the doses that have moved biomarkers in clinical trials. That means improved activation of protective proteins in bones and arteries. A dose of 90 micrograms showed effects on bone loss in postmenopausal women.5PubMed. Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study A dose of 180 micrograms improved both bone and cardiovascular markers across multiple trials.7PubMed. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein Higher doses up to 360 micrograms produced larger biomarker changes without reported safety issues in healthy people. No toxicity has been identified for K2 at these levels, which is partly why no formal upper limit has been set.
The practical takeaways: take it with food containing fat, choose an all-trans MK-7 product from a reputable manufacturer, and if you’re on warfarin, treat any K2 supplement as a medication interaction that needs professional oversight. For everyone else, the 100 to 200 microgram range is where most of the evidence sits, and it’s the range most supplement manufacturers have landed on. Whether the science eventually supports higher doses, or whether regulators will finally give K2 its own intake guidelines, remains to be seen.